A detailed history of Cullen Capital Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Cullen Capital Management, LLC holds 1,212,969 shares of JNJ stock, worth $202 Million. This represents 2.09% of its overall portfolio holdings.

Number of Shares
1,212,969
Previous 1,260,729 3.79%
Holding current value
$202 Million
Previous $199 Million 11.1%
% of portfolio
2.09%
Previous 2.27%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $6.9 Million - $7.54 Million
-47,760 Reduced 3.79%
1,212,969 $177 Million
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $53.2 Million - $55.8 Million
342,730 Added 37.33%
1,260,729 $199 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $65.5 Million - $71.5 Million
-449,773 Reduced 32.88%
917,999 $144 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $46.1 Million - $51.6 Million
-295,938 Reduced 17.79%
1,367,772 $213 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $2.82 Million - $3.03 Million
18,238 Added 1.11%
1,663,710 $275 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $61.4 Million - $73.3 Million
406,484 Added 32.81%
1,645,472 $255 Million
Q4 2022

Feb 16, 2023

SELL
$160.2 - $179.79 $62.2 Million - $69.8 Million
-388,232 Reduced 23.86%
1,238,988 $219 Million
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $42.9 Million - $47.8 Million
266,074 Added 19.55%
1,627,220 $266 Million
Q2 2022

Aug 11, 2022

SELL
$168.19 - $186.01 $2.46 Million - $2.72 Million
-14,637 Reduced 1.06%
1,361,146 $242 Million
Q1 2022

May 03, 2022

BUY
$158.14 - $179.59 $11.8 Million - $13.4 Million
74,457 Added 5.72%
1,375,783 $244 Million
Q4 2021

Feb 10, 2022

SELL
$155.93 - $173.01 $6.22 Million - $6.9 Million
-39,882 Reduced 2.97%
1,301,326 $223 Million
Q3 2021

Nov 05, 2021

BUY
$161.5 - $179.47 $1.66 Million - $1.85 Million
10,294 Added 0.77%
1,341,208 $217 Million
Q2 2021

Aug 04, 2021

BUY
$159.48 - $171.07 $16.1 Million - $17.3 Million
101,166 Added 8.23%
1,330,914 $219 Million
Q1 2021

May 10, 2021

BUY
$153.07 - $170.48 $137 Million - $153 Million
897,118 Added 269.7%
1,229,748 $202 Million
Q4 2020

Jan 26, 2021

SELL
$137.11 - $157.38 $9.5 Million - $10.9 Million
-69,290 Reduced 17.24%
332,630 $52.3 Million
Q3 2020

Nov 02, 2020

BUY
$140.38 - $153.83 $285,673 - $313,044
2,035 Added 0.51%
401,920 $59.8 Million
Q2 2020

Jul 31, 2020

SELL
$128.81 - $155.51 $8.89 Million - $10.7 Million
-69,055 Reduced 14.73%
399,885 $56.2 Million
Q1 2020

May 13, 2020

SELL
$111.14 - $153.99 $90 Million - $125 Million
-810,047 Reduced 63.34%
468,940 $61.5 Million
Q1 2020

May 05, 2020

BUY
$111.14 - $153.99 $83.6 Million - $116 Million
751,762 Added 142.59%
1,278,987 $168 Million
Q4 2019

Jan 31, 2020

BUY
$127.5 - $146.44 $972,187 - $1.12 Million
7,625 Added 1.47%
527,225 $76.9 Million
Q3 2019

Nov 15, 2019

BUY
$126.95 - $142.14 $229,144 - $256,562
1,805 Added 0.35%
519,600 $67.2 Million
Q2 2019

Jul 30, 2019

SELL
$131.15 - $144.24 $240,660 - $264,680
-1,835 Reduced 0.35%
517,795 $72.1 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $691,460 - $768,845
5,500 Added 1.07%
519,630 $72.6 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $4.94 Million - $5.95 Million
-40,240 Reduced 7.26%
514,130 $66.3 Million
Q3 2018

Nov 15, 2018

SELL
$121.58 - $142.88 $628,568 - $738,689
-5,170 Reduced 0.92%
554,370 $76.6 Million
Q2 2018

Aug 14, 2018

BUY
$119.4 - $131.76 $263,277 - $290,530
2,205 Added 0.4%
559,540 $67.9 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $516,037 - $611,077
4,125 Added 0.75%
557,335 $71.4 Million
Q4 2017

Feb 15, 2018

SELL
$131.22 - $143.62 $11.1 Million - $12.2 Million
-84,740 Reduced 13.28%
553,210 $77.3 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $165,721 - $173,286
1,280 Added 0.2%
637,950 $82.9 Million
Q2 2017

Aug 16, 2017

BUY
N/A
636,670
636,670 $84.2 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cullen Capital Management, LLC Portfolio

Follow Cullen Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cullen Capital Management, LLC with notifications on news.